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Bunyaviruses have evolved a variety of strategies to counteract the antiviral defence systems of
mammalian cells. Here we show that the NSs protein of Schmallenberg virus (SBV) induces the
degradation of the RPB1 subunit of RNA polymerase II and consequently inhibits global cellular
protein synthesis and the antiviral response. In addition, we show that the SBV NSs protein
enhances apoptosis in vitro and possibly in vivo, suggesting that this protein could be involved in
SBV pathogenesis in different ways.
Schmallenberg virus (SBV; family Bunyaviridae, genus
Orthobunyavirus) is a virus of ruminants that emerged
in 2011 (Hoffmann et al., 2012). SBV causes abortions,
stillbirths and malformations in cattle and sheep, and it is
believed to spread primarily by biting midges (Culicoides
spp.) (De Regge et al., 2012; Elbers et al., 2013; Rasmussen
et al., 2012; Schnettler et al., 2013). Despite sequence
diversity and genus-dependent expression strategies, the
NSs proteins of Bunyamwera virus (BUNV) and La Crosse
virus (LACV) (both genus Orthobunyavirus) and Rift Valley
fever virus (genus Phlebovirus) inhibit transcription and are
considered interferon (IFN) antagonists (Blakqori et al.,
2007; Bridgen et al., 2001; Habjan et al., 2009; Verbruggen
et al., 2011; Weber et al., 2002). We, and others, have
recently shown that the NSs protein of SBV also plays a
major role in inhibiting IFN production and that SBV
lacking the NSs protein is attenuated in vivo (Elliott et al.,
2013; Varela et al., 2013). In the current study, we further
investigated the roles of the SBV NSs protein.
We previously showed that WT SBV and a NSs deletion
mutant (SBVDNSs) do not differ in multiplication kinetics
in a sheep cell line lacking a fully functional IFN system
(CPT-Tert) (Arnaud et al., 2010; Varela et al., 2013). Here
we performed growth assays of SBV and SBVDNSs in
primary sheep endothelial cells, which have an intact IFN
system, and in CPT-Tert and human HEK-293T cells
(another weak producer of IFN). The multiplication
kinetics of SBVDNSs in primary endothelial cells was
strongly reduced compared with WT SBV, while there was
no difference between the viruses in CPT-Tert or HEK-
293T cells (Fig. 1a–c).
To test if SBV could block host-cell gene and protein
expression by suppressing transcription, translation or
both (which would consequently inhibit a strong antiviral
response), we first infected HEK-293T cells with WT SBV
or SBVDNSs at an m.o.i. of 1 and monitored nascent
protein synthesis by 35S-methionine (PerkinElmer) label-
ling (0.8 MBq ml21). We labelled cells for 2 h beginning
at either 6 h or 16 h post-infection (p.i.) (before the
appearance of cytopathic effect). Cells were then lysed, and
lysates were subjected to SDS-PAGE. Protein synthesis was
decreased in both WT SBV- and SBVDNSs-infected cells,
although this effect appeared less pronounced in the latter
(Fig. 1d) suggesting that NSs contributes to the inhibition
of host-cell gene expression in SBV-infected cells. Similar
results were seen in CPT-Tert cells (not shown). Interestingly,
the virus protein bands at 16 h (bands ‘L’, ‘Gc’ and ‘N’ on the
gel shown in Fig. 1d) were more prominent in SBVDNSs-
infected cells. The reasons for this are unclear, but it could
suggest that NSs plays a regulatory/inhibitory role in the
expression of other SBV proteins. This phenomenon has also
been observed in BUNV infections (Bridgen et al., 2001).
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Fig. 1. WT SBV (black line) or SBVDNSs (grey line) growth assays carried out in (a) primary sheep endothelial cells, (b) CPT-
Tert cells or (c) HEK-293T cells (m.o.i. 0.01). (d) SDS-PAGE of lysates from 35S-methionine-labelled HEK-293T cells infected
with WT SBV, SBVDNSs or mock. Gels were stained with Coomassie blue and then exposed to X-ray films (grey). Positions of
SBV proteins polimerase, glycoprotein and nucleocapsid are indicated as ‘L’, ‘Gc’ and ‘N’, respectively. (e) Luciferase activity in
HEK-293T cells transfected with a pRL-CMV plasmid (100 ng), infected with WT SBV, SBVDNSs or BUNV (m.o.i. 1) and then
lysed 24 h p.i. Values are relative to mock-infected cells (100%). (f) Luciferase activity in HEK-293T cells transfected with a
pRL-CMV plasmid (100 ng) and either 500 ng of empty plasmid or 50, 250 or 500 ng of a pCI plasmid expressing SBV NSs
and then lysed 24 h p.t. (g) Alignment of amino acid residues of the NSs protein of different bunyaviruses. Names on the left of
each sequence indicate the name of the virus and the corresponding GenBank accession number. SBV, Schmallenberg virus;
SHAV, Shamonda virus; DOUV, Douglas virus; AKV, Akabane virus; SATV, Sathuperi virus; LACV, La Crosse virus; CEV,
California encephalitis virus; SAV, San Angelo virus; JSV, Jerry Slough virus; JCV, Jamestown Canyon virus; MELV, Melao virus;
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To confirm these results, we used a luciferase-based assay
to quantify the inhibition of gene expression. HEK-293T
cells were transfected with pRL-CMV (Promega), a Renilla
luciferase-expressing plasmid. Cells were then infected with
WT SBV, SBVDNSs, BUNV (positive control) (Le´onard
et al., 2006) (m.o.i. 1) or mock at 16 h post-transfection
(p.t.), and luciferase activity was measured 24 h p.i. using
the Renilla-Glo Luciferase Assay System (Promega). Relative
luciferase values in cells infected by SBV and BUNV were
91% and 75%, respectively, lower than in mock-infected
cells. In contrast, relative luciferase values in SBVDNSs-
infected cells were only 45% lower than in mock-infected
cells (Fig. 1e). Similar results were seen in CPT-Tert cells
(not shown). These data confirmed that SBV NSs signifi-
cantly inhibits host-cell gene expression. Importantly, we
found a dose-dependent block of luciferase expression in
cells transfected simultaneously with varying amounts of a
pCI plasmid expressing the SBV NSs protein and a fixed
amount of the pRL-CMV plasmid (100 ng), indicating
that SBV NSs alone can inhibit cellular protein production
(Fig. 1f).
The structure of the NSs protein of SBV (or of any
other bunyavirus) has not been solved. To understand
what domains of the protein are involved in inhibiting
host-cell gene expression, we introduced several deletions
or substitutions in regions that are highly conserved across
a wide range of bunyaviruses (Fig. 1g). WT or mutant NSs
expression plasmids (500 ng) were transfected into HEK-
293T cells along with the pRL-CMV plasmid (100 ng),
and luciferase activity was measured 24 h p.t. (Fig. 1h).
Substitutions or deletions in the N-terminal region of
SBV NSs (H3A, S22del) had no effect on the NSs protein’s
ability to inhibit luciferase expression. In contrast, sub-
stitutions in the C-terminal region (167A, 169A and P82A)
significantly impaired NSs protein activity. We usedWestern
blotting to confirm expression of the mutant NSs proteins
in transfected HEK-293T cells (Fig. 1i) using an antiserum
against SBV NSs (GenScript). Expression, even of WT
SBV NSs, was difficult to detect with our reagents. The
NSs proteins of other bunyaviruses are known to be
rapidly degraded (Simons et al., 1992; van Knippenberg
et al., 2013; Vialat et al., 2000). Thus, the addition of the
proteosome inhibitor MG132 (10 mM) to the transfected
cells and high exposure times of the membranes during
blotting were required to visualize NSs expression (although
the signal was weak). These results suggest that the C-
terminal region of SBV NSs is critical for its inhibitory
function, similar to that in the BUNV NSs protein (Le´onard
et al., 2006). Interestingly, the NSs S22 del mutant showed a
high level of expression. The reason for this is unclear but
this mutation may stabilize NSs, thus reducing its degrada-
tion in a similar fashion to a mutation recently shown in
BUNV NSs (van Knippenberg et al., 2013).
Data from other bunyaviruses suggest that NSs may
reduce gene expression by targeting cellular RNA synthesis
(Habjan et al., 2009; Le´onard et al., 2006; Weber et al.,
2002). A Click-iT RNA assay (Life Technologies) was
used to detect newly synthesized RNA in HEK-293T cells
infected with WT SBV or SBVDNSs. This assay involves
labelling newly made RNA with a modified nucleoside,
5-ethynyl uridine. Cells are then fixed and a fluorescently
labelled molecule is ligated to the modified nucleoside.
This fluorescence can then be visualized by microscopy
(Jao & Salic, 2008). RNA levels in WT SBV-infected
cells were markedly lower than in SBVDNSs-infected cells
or uninfected cells, suggesting that the SBV NSs protein
reduces cellular RNA levels (Fig. 2a).
BUNV NSs blocks the phosphorylation of the C terminus
of the RPB1 subunit of RNA polymerase II (RNAP II)
(Le´onard et al., 2006; Thomas et al., 2004; van Knippenberg
et al., 2010). In contrast, LACV NSs triggers the degradation
of RPB1 (Verbruggen et al., 2011). To examine whether SBV
NSs targets the RNAP II complex, we infected HEK-293T
cells with WT SBV, SBVDNSs or BUNV (m.o.i. 1) and
analysed cell lysates 24 h p.i. by Western blot using
antibodies specific for RPB1 (Santa Cruz), a phosphorylated
form of RPB1 (RPB1 pSer2, Covance), SBV N protein
(Varela et al., 2013), BUNV N protein (Proteintech Group)
and c-tubulin (Sigma). While RPB1 expression was un-
detectable in BUNV- and SBV-infected cells, expression
remained strong in SBVDNSs-infected cells (Fig. 2b).
However, it was unclear whether SBV NSs caused degrada-
tion of the RPB1 protein similarly to LACV NSs or inhibited
phosphorylation (and thus indirectly allowed RPB1
degradation) like BUNV. Therefore, HEK-293T cells were
infected with WT SBV (m.o.i. 1) and grown with or without
the proteasome inhibitor MG132 (10 mM). We found
that RPB1 was degraded over time (6–15 h p.i.), but
this degradation was delayed by MG132. RPB1 pSer2
KEY, Keystone virus; LUMV, Lumbo virus; TVTV, Trivittatus virus; BUNV, Bunyamwera virus. Highlighted in grey are amino acid
residues that were substituted with an alanine (shown as an ‘A’ above the highlighted region) or deleted (‘del’ above the
highlighted region). (h) Luciferase activity in HEK-293T cells transfected with pRL-CMV (100 ng) and pCI plasmid (500 ng)
expressing either WT SBV NSs, one of the mutant versions of SBV NSs or an empty plasmid and lysed 24 h p.t. Values are
relative to mock-infected cells (100%). (i) Western blot for SBV NSs and c-tubulin using lysates from HEK-293T cells
transfected with pRL-CMV (100 ng) and pCI plasmid (500 ng) expressing WT NSs or one of the mutant versions of NSs
shown in (g). Cells were treated with MG132 (10 mM) 8 h p.t. and lysed 24 h p.t. Note that expression of the deletion mutant
S35-38 del could not be confirmed and consequently was not used further. All assays shown in this figure were performed a
minimum of three times and each assay was performed in triplicate. Statistically significant differences are indicated by asterisks
(*P,0.05, **P,0.01; one-way ANOVA). Error bars indicate SD.
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disappeared along with RPB1, suggesting that SBV NSs
targets RPB1 for proteasomal degradation rather than
dephosphorylation (Fig. 2c).
RPB1 has a half-life of approximately 6 h in mammalian
cells (Akhrymuk et al., 2012). The loss of RPB1 could be a
direct result of NSs-induced degradation or an indirect
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global effect on cellular transcription. To evaluate these two
possibilities, we assessed RPB1 expression in cells treated
with actinomycin D (a transcription inhibitor) or infected
with WT SBV (m.o.i. 1) at different times post-treatment.
RPB1 expression decreased dramatically at approximately
9–10 h p.i., whereas it persisted until at least 12 h post-
actinomycin D treatment (Fig. 2d). These data strongly
suggest that the loss of RPB1 is directly induced by SBV
NSs expression and not the indirect result of inhibition of
cellular transcription. Crucially, by measuring expression
in the luciferase assay and via comparison with RPB1
expression in control cells transfected with empty plasmids,
we detected a reduction in RPB1 levels in cells transfected
with expression plasmids for SBV NSs or with the NSs
mutants H3A and S22 del. On the other hand, the levels
of RBP1 in cells transfected with expression plasmids for
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those NSs mutants that did not show any inhibitory
activity in luciferase assays (I67A, I69A and P82A) were
comparable to those in the control cells (Fig. 2e).
The NSs proteins of many bunyaviruses also affect cellular
apoptosis. The NSs protein of BUNV can reduce or delay
cell death by counteracting the activity of IRF-3 (Kohl et al.,
2003), while LACV NSs appears to enhance apoptosis
(Colo´n-Ramos et al., 2003; Pekosz et al., 1996). To inves-
tigate the role of the SBV NSs protein in apoptosis,
we infected CPT-Tert cells with WT SBV or SBVDNSs
and measured activated caspase-3/7 in cell lysates using
the Caspase-Glo 3/7 Assay kit (Promega). The amount
of activated caspase-3/7 in WT SBV–infected cells was
significantly higher than in mock- or SBVDNSs-infected
cells (Fig. 3a). Importantly, caspase-3/7 activation slightly
but significantly increased in cells transfected with a plasmid
expressing the SBV NSs protein compared with activation
in cells transfected with empty plasmid (Fig. 3b). Similar
results were observed in HEK-293T cells (not shown). Thus,
it appears that similar to LACV NSs, SBV NSs enhances the
rate of apoptotic cell death. To assess the relevance of these
observations in vivo, we infected newborn NIH-Swiss mice
intracerebrally with WT SBV or SBVDNSs virus (400 p.f.u.,
two mice per group per time point). Brains were collected
at 48, 72, 96 and 120 h post-inoculation and stained for
the presence of SBV N protein and activated caspase-3
(Cell Signalling) by immunohistochemistry. Cells positive
for either activated caspase-3 or SBV N protein were
counted in different fields, in three different areas of the
brain (cerebellum, cerebrum and brainstem), and the mean
number of positive cells per mm2 was recorded. Although
differences were not statistically significant, brain sections
collected from mice infected with WT SBV contained a
higher proportion of caspase-3-positive cells than those
infected with SBVDNSs, supporting a role for the SBV NSs
protein in apoptosis (Fig. 3c, d).
In conclusion, our data provide insight into the functions
of the NSs protein of a newly emerged bunyavirus of
ruminants. The SBV NSs protein targets the RPB1 subunit
of RNAP II for degradation, preventing transcription in
infected cells and consequently de novo protein synthesis.
Inhibition of cellular transcription leads to a reduction in
IFN production that favours SBV replication and spread
and thus contributes to pathogenesis. Indeed, replication of
SBVDNSs is grossly impaired in IFN-competent primary
sheep cells, while it is identical to WT SBV in IFN-
incompetent cell lines, showing that virus targeting of the
cellular transcriptional machinery is essential to overcome
an intact antiviral response. Finally, we found evidence
supporting a pro-apoptotic role for SBV NSs protein
(similar to LACV NSs, but in contrast to BUNV NSs),
which may also contribute to viral pathogenesis.
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